SCHEMBL2918697

SCHEMBL2918697

COC(=O)c1ccc(F)cc1C(C(=O)O)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.44
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
GAA P10253 2/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
ATM Q13315 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 1/20 0.42
CASP3 P42574 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13324495 0.87 SLC6A4 (0.43) FFAR4SLC6A4SLC6A3GAAKDM4E
SCHEMBL2919219 0.87 SLC6A4 (0.43) FFAR4SLC6A4SLC6A3GAAKDM4E
SCHEMBL18375724 0.83 SLC6A4 (0.45) FFAR4SLC6A4SLC6A3GAAKDM4E
SCHEMBL18435947 0.82 NPC1 (0.47) FFAR4SLC6A4SLC6A3GAAKDM4E
SCHEMBL22907273 0.81 SLC6A4 (0.43) FFAR4SLC6A4SLC6A3GAAKDM4E
SCHEMBL16954821 0.81 SLC6A4 (0.43) FFAR4SLC6A4SLC6A3GAAKDM4E
SCHEMBL18436612 0.78 FFAR4 (0.42) FFAR4SLC6A4SLC6A3GAAKDM4E
SCHEMBL8802959 0.77 KEAP1 (0.42) FFAR4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL2708451 0.77 SLC6A4 (0.51) FFAR4SLC6A4SLC6A3GAAKDM4E
SCHEMBL30301996 0.77 SLC6A4 (0.51) FFAR4SLC6A4SLC6A3GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478624-B1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2010-09-08 EP disclosed
US-7709500-B2 Chemical compounds ASTRAZENECA AB (SE) 2010-05-04 US disclosed
US-20050107428-A1 Chemical compounds ASTRAZENECA AB (SE) 2005-05-19 US disclosed
EP-1478624-A1 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2004-11-24 EP disclosed
WO-2003068743-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2003-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107428-A1 Chemical compounds CCR10, CCR3, CXCR5 FFAR4 715/4885SLC6A4 2650/4885SLC6A3 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.